Dalian BIO-CHEM Company Limited (603360.SS)
CNY 28.36
(1.29%)
CNY 28.36
(1.29%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -388.72 Million CNY | -34.58% |
| 2022 | -288.84 Million CNY | -747.27% |
| 2021 | 44.62 Million CNY | 234.95% |
| 2020 | -33.06 Million CNY | 84.41% |
| 2019 | -212.07 Million CNY | -196.18% |
| 2018 | -71.6 Million CNY | 46.66% |
| 2017 | -134.24 Million CNY | -243.47% |
| 2016 | -39.08 Million CNY | -153.36% |
| 2015 | 73.24 Million CNY | -40.6% |
| 2014 | 123.3 Million CNY | 11.19% |
| 2013 | 110.88 Million CNY | -8.44% |
| 2012 | 121.11 Million CNY | 49.12% |
| 2011 | 81.21 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -262.72 Million CNY | -5.61% |
| 2024 Q1 | -318.45 Million CNY | 18.08% |
| 2024 Q2 | -248.75 Million CNY | 21.89% |
| 2023 Q1 | -387.01 Million CNY | -33.98% |
| 2023 FY | -388.72 Million CNY | -34.58% |
| 2023 Q2 | -266.59 Million CNY | 31.12% |
| 2023 Q4 | -388.72 Million CNY | -4.7% |
| 2023 Q3 | -371.28 Million CNY | -39.27% |
| 2022 FY | -288.84 Million CNY | -747.27% |
| 2022 Q4 | -288.84 Million CNY | -54.32% |
| 2022 Q3 | -187.17 Million CNY | -464.86% |
| 2022 Q2 | -33.13 Million CNY | -1115.7% |
| 2022 Q1 | -2.72 Million CNY | -106.11% |
| 2021 Q2 | 133.43 Million CNY | 228.87% |
| 2021 Q1 | 40.57 Million CNY | 222.7% |
| 2021 FY | 44.62 Million CNY | 234.95% |
| 2021 Q4 | 44.62 Million CNY | -74.06% |
| 2021 Q3 | 172.04 Million CNY | 28.93% |
| 2020 Q4 | -33.06 Million CNY | 82.44% |
| 2020 Q3 | -188.33 Million CNY | -23.5% |
| 2020 FY | -33.06 Million CNY | 84.41% |
| 2020 Q1 | -283.17 Million CNY | -33.52% |
| 2020 Q2 | -152.48 Million CNY | 46.15% |
| 2019 Q3 | -128.52 Million CNY | -34.57% |
| 2019 FY | -212.07 Million CNY | -196.18% |
| 2019 Q4 | -212.07 Million CNY | -65.01% |
| 2019 Q2 | -95.5 Million CNY | -25.05% |
| 2019 Q1 | -76.37 Million CNY | -6.66% |
| 2018 Q2 | -222.07 Million CNY | -155.59% |
| 2018 Q3 | -125.28 Million CNY | 43.58% |
| 2018 Q1 | -86.88 Million CNY | 35.28% |
| 2018 Q4 | -71.6 Million CNY | 42.85% |
| 2018 FY | -71.6 Million CNY | 46.66% |
| 2017 Q1 | -320.05 Million CNY | -718.86% |
| 2017 Q4 | -134.24 Million CNY | -1.58% |
| 2017 Q3 | -132.15 Million CNY | 56.2% |
| 2017 Q2 | -301.73 Million CNY | 5.72% |
| 2017 FY | -134.24 Million CNY | -243.47% |
| 2016 FY | -39.08 Million CNY | -153.36% |
| 2016 Q2 | 33.75 Million CNY | 26.15% |
| 2016 Q4 | -39.08 Million CNY | -39810.85% |
| 2016 Q3 | -97.93 Thousand CNY | -100.29% |
| 2016 Q1 | 26.75 Million CNY | -63.47% |
| 2015 Q4 | 73.24 Million CNY | 0.0% |
| 2015 FY | 73.24 Million CNY | -40.6% |
| 2014 FY | 123.3 Million CNY | 11.19% |
| 2014 Q4 | 123.3 Million CNY | 0.0% |
| 2014 Q1 | 120.34 Million CNY | 0.0% |
| 2014 Q2 | 120.34 Million CNY | 0.0% |
| 2013 FY | 110.88 Million CNY | -8.44% |
| 2012 FY | 121.11 Million CNY | 49.12% |
| 2011 FY | 81.21 Million CNY | 0.0% |